ROSWELL, Ga. — May 5, 2026 — Leads & Copy — Cellution Biologics Inc. has expanded its U.S. headquarters in Roswell, Georgia. The regenerative medicine company, which focuses on human-tissue based products, announced the expansion alongside plans to commemorate the milestone with a ribbon cutting ceremony.
Senior leadership, employees, and invited guests will attend the ceremony. Mayur Abhaya, Managing Director of LifeCell International, Cellution Biologics’ parent company, and Shiva Arjunon, President of Cellution Biologics, will also be in attendance.
According to the company, the event highlights its commitment to strengthening its presence in the United States and supporting its growing customer base.
The expanded Roswell facility will house corporate offices, warehousing and distribution capabilities, and enhanced customer support services. The company said the investment is designed to improve operational efficiency, streamline logistics, and elevate the level of service provided to healthcare providers nationwide.
Arjunon said the expansion represents an important step forward in the company’s mission to deliver innovative solutions to clinicians and their patients. He added that by enhancing their infrastructure, they are better positioned to support their customers with speed, reliability, and a high standard of service.
Abhaya added that the growth of Cellution Biologics reflects their broader commitment to expanding access to advanced biologic solutions globally, and that the Roswell headquarters will serve as a key hub in delivering on that vision in the United States.
The ribbon cutting ceremony will take place on Tuesday, May 5, 2026, at the Roswell headquarters. The company said the event marks a significant milestone in Cellution Biologics’ continued growth and reinforces its dedication to innovation, operational excellence, and customer support.
Cellution Biologics Inc. specializes in the development and commercialization of human tissue-based products designed to support healing across a range of clinical applications. The company says it is committed to advancing patient care through innovation, quality, and collaboration with healthcare professionals.
LifeCell International develops and delivers biologic solutions that improve patient outcomes. Through its subsidiaries, including Cellution Biologics Inc., LifeCell continues to expand its global footprint in advanced wound care and surgical applications.
Source: Cellution Biologics Inc.
